Jonathan D Alpern

6PUBLICATIONS
2CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical parasitologyGene and molecular therapyMedical bacteriologyPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 03, 2023
Factors Associated With Adherence to First-line Antiviral Therapy Among Commercially Insured Patients With Chronic Hepatitis B.

Jonathan D Alpern, Heesoo Joo, Nathan C Bahr

|Jan 31, 2023
Costs of malaria treatment in the United States.

Joohyun Park, Heesoo Joo, Brian A Maskery

|Sep 03, 2022
Food and Drug Administration Approval of Artesunate for Severe Malaria: Enough to Achieve Best Practice?

Christine M Thomas, William M Stauffer, Jonathan D Alpern

|Aug 26, 2022
Blastomycosis-Some Progress but Still Much to Learn.

Matthew F Pullen, Jonathan D Alpern, Nathan C Bahr

|Apr 12, 2019
Broken drug markets in infectious diseases: Opportunities outside the private sector?

Jonathan D Alpern, Stephen J Dunlop, William M Stauffer

|Sep 15, 2017
Access to benznidazole for Chagas disease in the United States-Cautious optimism?

Jonathan D Alpern, Rogelio Lopez-Velez, William M Stauffer

Pageof 1

Frequent Collaborators

1 joint publications

Nathan C Bahr

1 joint publications

Joohyun Park